Homrich & Berg’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-3,224
Closed -$256K 343
2018
Q2
$256K Sell
3,224
-856
-21% -$71.1K 0.02% 274
2018
Q1
$364K Sell
4,080
-91
-2% -$8.74K 0.03% 237
2017
Q4
$435K Sell
4,171
-288
-6% -$32.5K 0.03% 216
2017
Q3
$650K Sell
4,459
-191
-4% -$26K 0.05% 159
2017
Q2
$604K Sell
4,650
-1,287
-22% -$158K 0.05% 152
2017
Q1
$739K Sell
5,937
-232
-4% -$27.8K 0.06% 120
2016
Q4
$714K Sell
6,169
-717
-10% -$79.8K 0.06% 118
2016
Q3
$720K Buy
6,886
+141
+2% +$15.3K 0.07% 116
2016
Q2
$665K Buy
6,745
+3,183
+89% +$329K 0.06% 112
2016
Q1
$357K Sell
3,562
-298
-8% -$30.7K 0.04% 172
2015
Q4
$462K Buy
3,860
+465
+14% +$53.8K 0.04% 155
2015
Q3
$367K Sell
3,395
-1,365
-29% -$169K 0.04% 173
2015
Q2
$551K Sell
4,760
-101
-2% -$11.5K 0.05% 134
2015
Q1
$560K Buy
4,861
+650
+15% +$77.7K 0.06% 137
2014
Q4
$471K Buy
4,211
+1,016
+32% +$107K 0.05% 148
2014
Q3
$303K Buy
+3,195
New +$288K 0.03% 193

Other funds holding CELG

Homrich & Berg's CELG Position: Q3 2018 in Review

Homrich & Berg sold out of Celgene Corp (CELG) in Q3 2018, closing a stake of 3,224 shares — an estimated $256K sold.

Homrich & Berg first reported a position in CELG in Q3 2014 and held it in 16 quarters. The position peaked at $739K in Q1 2017. 1,364 funds tracked by Wall St. Rank hold CELG as of Q3 2018.

  • Homrich & Berg reported no remaining Celgene Corp position as of Q3 2018 after selling out during the quarter.
  • Homrich & Berg sold 3,224 Celgene Corp shares in Q3 2018, an estimated $256K.
  • Homrich & Berg first reported a position in Celgene Corp in Q3 2014 and held it in 16 quarters.
  • Homrich & Berg's Celgene Corp position peaked at $739K in Q1 2017.
  • 1,364 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2018.

Based on Homrich & Berg's 13F filing for Q3 2018, filed 13 Nov 2018.